Hematopoietic Stem Cell Transplantation for Patients with Sickle Cell Disease
- 1 December 2014
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 28 (6) , 1171-1185
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamideBest Practice & Research Clinical Haematology, 2011
- Umbilical Cord Blood Transplantation for Children with Thalassemia and Sickle Cell DiseaseTransplantation and Cellular Therapy, 2011
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2010
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemiaNature, 2010
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- Fludarabine-Based Nonmyeloablative Stem Cell Transplantation for Sickle Cell Disease with and without Renal Failure: Clinical Outcome and PharmacokineticsTransplantation and Cellular Therapy, 2007
- Persistence of fetal hemoglobin production after successful transplantation of cord blood stem cells in a patient with sickle cell anemiaThe Journal of Pediatrics, 1996
- BONE MARROW TRANSPLANTATION IN FIVE CHILDREN WITH SICKLE CELL ANAEMIAThe Lancet, 1988
- Marrow Transplantation in Patients with Advanced ThalassemiaNew England Journal of Medicine, 1987
- Bone-Marrow Transplantation in a Patient with Sickle-Cell AnemiaNew England Journal of Medicine, 1984